Please enable JavaScript to continue using this application.

Compare $ALMR vs $DNA | Chartloom

Compare

$ALMR vs $DNA

Alamar Biosciences Inc · Ginkgo Bioworks Holdings Inc

ALMR

Alamar Biosciences Inc

DNA

Ginkgo Bioworks Holdings Inc

Compare $ALMR vs $DNA

Comparing Alamar Biosciences Inc and Ginkgo Bioworks Holdings Inc

ALMRAlamar Biosciences Inc

DNAGinkgo Bioworks Holdings Inc

ALMRAlamar Biosciences Inc

Market cap

$1.75B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.35x

Rev growth (TTM)

—

YTD performance

14.9%

52W performance

14.9%

FCF yield

0.0%

DNAGinkgo Bioworks Holdings Inc

Market cap

$810M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-51.5%

YTD performance

49.4%

52W performance

-19.2%

FCF yield

-21.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALMR

DNA

Detailed metrics comparison

ALMR

Alamar Biosciences Inc

DNA

Ginkgo Bioworks Holdings Inc

Market Cap

ALMR$1.75B

DNA$810M

Enterprise Value

ALMR$1.63B

DNA$726M

Price

ALMR$25.27

DNA$13.00

P/E Ratio

ALMRN/A

DNAN/A

P/S Ratio

ALMR31.58x

DNA7.24x

EV/Sales

ALMR29.36x

DNA6.49x

EV/EBITDA

ALMR0.00x

DNA0.00x

P/B Ratio

ALMR7.62x

DNA1.98x

P/FCF Ratio

ALMRN/A

DNAN/A

EV/FCF

ALMR0.00x

DNA-4.15x

PEG Ratio

ALMRN/A

DNAN/A

Forward P/E (NTM)

ALMRN/A

DNAN/A

Forward P/S (NTM)

ALMR12.35x

DNAN/A

Revenue (TTM)

ALMR$55M

DNA$112M

Revenue Growth (YoY)

ALMRN/A

DNA-51.5%

Forward Rev Growth

ALMR39.6%

DNA13.4%

Gross Margin (TTM)

ALMR58.0%

DNA77.7%

Operating Margin (TTM)

ALMR0.0%

DNA0.0%

EBITDA Margin (TTM)

ALMR-45.8%

DNA-210.7%

Net Margin (TTM)

ALMR-62.2%

DNA-260.0%

FCF Margin (TTM)

ALMR0.0%

DNA-156.3%

Net Income (TTM)

ALMR$-35M

DNA$-291M

FCF (TTM)

ALMR$0

DNA$-175M

EPS (TTM)

ALMR-$0.50

DNA-$4.68

ROE (TTM)

ALMR0.0%

DNA-6021.0%

ROA (TTM)

ALMR0.0%

DNA-2685.0%

ROIC (TTM)

ALMR0.0%

DNA-6021.0%

Cash

ALMR$133M

DNA$85M

Debt

ALMR$10M

DNA$0

Net Cash/Debt

ALMR$123M

DNA$85M

Current Ratio (TTM)

ALMR11.85x

DNA4.57x

Quick Ratio (TTM)

ALMR9.67x

DNA4.37x

Debt/Equity (TTM)

ALMR0.03x

DNA0.00x

Debt/Assets (TTM)

ALMR0.0%

DNA0.0%

Interest Coverage (TTM)

ALMRN/A

DNAN/A

Net Debt/EBITDA (TTM)

ALMR0.00x

DNA0.00x

Beta

ALMR-0.30

DNA1.69

52W Performance

ALMR14.9%

DNA-19.2%

YTD Performance

ALMR14.9%

DNA49.4%

% from 52W High

ALMR-36.2%

DNA-28.6%

% from 52W Low

ALMR34.1%

DNA142.1%

Asset Turnover (TTM)

ALMR0.00x

DNA0.10x

FCF Yield (TTM)

ALMR0.0%

DNA-21.6%

Earnings Yield (TTM)

ALMR-2.0%

DNA-35.9%

Dividend Yield (TTM)

ALMRN/A

DNAN/A

Rule of 40

ALMR0.0

DNA-207.8

EV/GP/RG

ALMR0.30

DNA0.42

Ticker research

View ALMR research View DNA research

Metric	ALMR Alamar Biosciences Inc	DNA Ginkgo Bioworks Holdings Inc
Market & Valuation
Market Cap	$1.75B	$810M
Enterprise Value	$1.63B	$726M
Price	$25.27	$13.00
P/E Ratio	N/A	N/A
P/S Ratio	31.58x	7.24x
EV/Sales	29.36x	6.49x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.62x	1.98x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-4.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.35x	N/A
Revenue & Growth
Revenue (TTM)	$55M	$112M
Revenue Growth (YoY)	N/A	-51.5%
Forward Rev Growth	39.6%	13.4%
Profitability
Gross Margin (TTM)	58.0%	77.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-45.8%	-210.7%
Net Margin (TTM)	-62.2%	-260.0%
FCF Margin (TTM)	0.0%	-156.3%
Net Income (TTM)	$-35M	$-291M
FCF (TTM)	$0	$-175M
EPS (TTM)	-$0.50	-$4.68
ROE (TTM)	0.0%	-6021.0%
ROA (TTM)	0.0%	-2685.0%
ROIC (TTM)	0.0%	-6021.0%
Financial Health
Cash	$133M	$85M
Debt	$10M	$0
Net Cash/Debt	$123M	$85M
Current Ratio (TTM)	11.85x	4.57x
Quick Ratio (TTM)	9.67x	4.37x
Debt/Equity (TTM)	0.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.30	1.69
52W Performance	14.9%	-19.2%
YTD Performance	14.9%	49.4%
% from 52W High	-36.2%	-28.6%
% from 52W Low	34.1%	142.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.10x
FCF Yield (TTM)	0.0%	-21.6%
Earnings Yield (TTM)	-2.0%	-35.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-207.8
EV/GP/RG	0.30	0.42
Ticker research	View ALMR research	View DNA research

Valuation

P/S Ratio

DNA

7.24x

ALMR

31.58x

EV/FCF

DNA

-4.15x

ALMR

0.00x

Growth & revenue

Revenue Growth TTM

DNA

-51.5%

Forward Revenue Growth

ALMR

39.6%

DNA

13.4%

Profitability & performance

Gross Margin

DNA

77.7%

ALMR

58.0%

ROE

ALMR

0.0%

DNA

-6021.0%

FCF Yield %

ALMR

0.0%

DNA

-21.6%

52-Week Performance

ALMR

14.9%

DNA

-19.2%

Detailed metrics comparison

ALMR

Alamar Biosciences Inc

DNA

Ginkgo Bioworks Holdings Inc

Market Cap

ALMR$1.75B

DNA$810M

Enterprise Value

ALMR$1.63B

DNA$726M

Price

ALMR$25.27

DNA$13.00

P/E Ratio

ALMRN/A

DNAN/A

P/S Ratio

ALMR31.58x

DNA7.24x

EV/Sales

ALMR29.36x

DNA6.49x

EV/EBITDA

ALMR0.00x

DNA0.00x

P/B Ratio

ALMR7.62x

DNA1.98x

P/FCF Ratio

ALMRN/A

DNAN/A

EV/FCF

ALMR0.00x

DNA-4.15x

PEG Ratio

ALMRN/A

DNAN/A

Forward P/E (NTM)

ALMRN/A

DNAN/A

Forward P/S (NTM)

ALMR12.35x

DNAN/A

Revenue (TTM)

ALMR$55M

DNA$112M

Revenue Growth (YoY)

ALMRN/A

DNA-51.5%

Forward Rev Growth

ALMR39.6%

DNA13.4%

Gross Margin (TTM)

ALMR58.0%

DNA77.7%

Operating Margin (TTM)

ALMR0.0%

DNA0.0%

EBITDA Margin (TTM)

ALMR-45.8%

DNA-210.7%

Net Margin (TTM)

ALMR-62.2%

DNA-260.0%

FCF Margin (TTM)

ALMR0.0%

DNA-156.3%

Net Income (TTM)

ALMR$-35M

DNA$-291M

FCF (TTM)

ALMR$0

DNA$-175M

EPS (TTM)

ALMR-$0.50

DNA-$4.68

ROE (TTM)

ALMR0.0%

DNA-6021.0%

ROA (TTM)

ALMR0.0%

DNA-2685.0%

ROIC (TTM)

ALMR0.0%

DNA-6021.0%

Cash

ALMR$133M

DNA$85M

Debt

ALMR$10M

DNA$0

Net Cash/Debt

ALMR$123M

DNA$85M

Current Ratio (TTM)

ALMR11.85x

DNA4.57x

Quick Ratio (TTM)

ALMR9.67x

DNA4.37x

Debt/Equity (TTM)

ALMR0.03x

DNA0.00x

Debt/Assets (TTM)

ALMR0.0%

DNA0.0%

Interest Coverage (TTM)

ALMRN/A

DNAN/A

Net Debt/EBITDA (TTM)

ALMR0.00x

DNA0.00x

Beta

ALMR-0.30

DNA1.69

52W Performance

ALMR14.9%

DNA-19.2%

YTD Performance

ALMR14.9%

DNA49.4%

% from 52W High

ALMR-36.2%

DNA-28.6%

% from 52W Low

ALMR34.1%

DNA142.1%

Asset Turnover (TTM)

ALMR0.00x

DNA0.10x

FCF Yield (TTM)

ALMR0.0%

DNA-21.6%

Earnings Yield (TTM)

ALMR-2.0%

DNA-35.9%

Dividend Yield (TTM)

ALMRN/A

DNAN/A

Rule of 40

ALMR0.0

DNA-207.8

EV/GP/RG

ALMR0.30

DNA0.42

Ticker research

View ALMR research View DNA research

Metric	ALMR Alamar Biosciences Inc	DNA Ginkgo Bioworks Holdings Inc
Market & Valuation
Market Cap	$1.75B	$810M
Enterprise Value	$1.63B	$726M
Price	$25.27	$13.00
P/E Ratio	N/A	N/A
P/S Ratio	31.58x	7.24x
EV/Sales	29.36x	6.49x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.62x	1.98x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-4.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.35x	N/A
Revenue & Growth
Revenue (TTM)	$55M	$112M
Revenue Growth (YoY)	N/A	-51.5%
Forward Rev Growth	39.6%	13.4%
Profitability
Gross Margin (TTM)	58.0%	77.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-45.8%	-210.7%
Net Margin (TTM)	-62.2%	-260.0%
FCF Margin (TTM)	0.0%	-156.3%
Net Income (TTM)	$-35M	$-291M
FCF (TTM)	$0	$-175M
EPS (TTM)	-$0.50	-$4.68
ROE (TTM)	0.0%	-6021.0%
ROA (TTM)	0.0%	-2685.0%
ROIC (TTM)	0.0%	-6021.0%
Financial Health
Cash	$133M	$85M
Debt	$10M	$0
Net Cash/Debt	$123M	$85M
Current Ratio (TTM)	11.85x	4.57x
Quick Ratio (TTM)	9.67x	4.37x
Debt/Equity (TTM)	0.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.30	1.69
52W Performance	14.9%	-19.2%
YTD Performance	14.9%	49.4%
% from 52W High	-36.2%	-28.6%
% from 52W Low	34.1%	142.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.10x
FCF Yield (TTM)	0.0%	-21.6%
Earnings Yield (TTM)	-2.0%	-35.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-207.8
EV/GP/RG	0.30	0.42
Ticker research	View ALMR research	View DNA research